Courtney Flaherty News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ganjoo Discusses Treatment Plans, Patient Conversations, and the Role of Nab-Sirolimus in Malignant PEComa

Dr Ganjoo discusses unmet needs for patients with malignant PEComa, treatment plan considerations, and the use of nab-sirolimus in this disease.

United statesCourtney flahertyKristenn ganjooAadi biosciencesStanford health careLive on airStanford medicineOnclive on airApple podcastsGoogle podcastsAmazon music

Kummar on the Investigation of Rezatapopt in TP53 Y220C–Mutated Advanced Solid Tumors

Kummar on the Investigation of Rezatapopt in TP53 Y220C–Mutated Advanced Solid Tumors
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesShivaani kummarCourtney flahertyKnight cancer instituteCancer researchDivision of hematology medical oncologyOregon health science university school of medicineLive on airLester dearmond endowed chairMedical oncologyOregon healthScience university schoolExperimental therapeuticsKnight cancerOnclive on airApple podcasts

Bou Farhat and Nassar on the Use of NGS Mutation Signature vs IHC for Identifying dMMR Tumors

Drs Nassar and Bou Farhat explain how tumor-only NGS could address the limitations of IHC testing for MMR mutation signatures across several tumor types.

United statesYale universityNew havenElias bou farhatCourtney flahertyAmin nassarAbou farhatDepartment of medicine at brighamLive on airDrs nassarOnclive on airApple podcastsGoogle podcastsAmazon musicListen notesPodcast addict

FDA Approval Insights: Ponatinib in Ph+ ALL

Dr Jabbour expands on the FDA approval of ponatinib for patients with Ph-positive ALL, the agent’s mechanism of action, and data from the PhALLCON trial.

United statesElias jabbourCourtney flahertyUniversity of texas md anderson cancer centerDivision of cancer medicineDepartment of leukemiaLive on airCancer medicineCancer centerOnclive on airApple podcastsGoogle podcastsAmazon musicFda approval of ponatinibPatients with ph positive allPhallcon trial

Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers

Drs Monk and Tarantino highlight current research investigating B7-H4–directed antibody-drug conjugates. in multiple solid tumor types.

United statesDana farber cancer instituteWest palm beachPaolo tarantinoCourtney flahertyEuropean institute of oncologyLive on airLate stage clinical research programFlorida cancer specialistsResearch instituteWest palmEuropean instituteDrs monkOnclive on airApple podcastsGoogle podcasts